This page in Swedish

Ove Andrén

Title: Adjunct Professor School/office: School of Medical Sciences

Email:

Phone: +46 19 303000

Room: -

Research Subject

Research environments

Research Projects

Research Teams

Research Teams

Publications

Publications

Articles in journals |  Articles, reviews/surveys |  Doctoral theses, comprehensive summaries |  Manuscripts | 

Articles in journals

Ugge, H. , Downer, M. K. , Carlsson, J. , Bowden, M. , Davidsson, S. , Mucci, L. A. , Fall, K. , Andersson, S. & et al. (2019). Circulating inflammation markers and prostate cancer. The Prostate.
Erlandsson, A. , Carlsson, J. , Lundholm, M. , Fält, A. , Andersson, S. , Andrén, O. & Davidsson, S. (2019). M2 macrophages and regulatory T cells in lethal prostate cancer. The Prostate, 79 (4), 363-369.
Ugge, H. , Udumyan, R. , Carlsson, J. , Andrén, O. , Montgomery, S. , Davidsson, S. & Fall, K. (2018). Acne in late adolescence and risk of prostate cancer. International Journal of Cancer, 1580-1585.
Ugge, H. , Udumyan, R. , Carlsson, J. , Davidsson, S. , Andrén, O. , Montgomery, S. & Fall, K. (2018). Appendicitis before age 20 years is associated with an increased risk of later prostate cancer. Cancer Epidemiology, Biomarkers and Prevention, 27 (6), 660-664.
Erlandsson, A. , Carlsson, J. , Andersson, S. , Vyas, C. , Wikström, P. , Andrén, O. , Davidsson, S. & Rider, J. R. (2018). High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer. Scandinavian journal of urology, 52 (2), 129-133.
Davidsson, S. , Carlsson, J. , Giunchi, F. , Harlow, A. , Kirrander, P. , Rider, J. , Fiorentino, M. & Andrén, O. (2018). PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. European Urology Oncology.
Carlsson, J. , Davidsson, S. , Fridfeldt, J. , Giunchi, F. , Fiano, V. , Grasso, C. , Zelic, R. , Richiardi, L. & et al. (2018). Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies. BMC Medical Research Methodology, 18 (1).
Bill-Axelson, A. , Holmberg, L. , Garmo, H. , Taari, K. , Busch, C. , Nordling, S. , Häggman, M. , Andersson, S. & et al. (2018). Radical Prostatectomy or Watchful Waiting in Prostate Cancer-29-Year Follow-up. New England Journal of Medicine, 379 (24), 2319-2329.
Ugge, H. , Carlsson, J. , Söderquist, B. , Fall, K. , Andrén, O. & Davidsson, S. (2018). The influence of prostatic Cutibacterium acnes infection on serum levels of IL6 and CXCL8 in prostate cancer patients. Infectious Agents and Cancer, 13.
Mushtaq, M. , Jensen, L. , Davidsson, S. , Grygoruk, O. V. , Andrén, O. , Kashuba, V. & Kashuba, E. (2018). The MRPS18-2 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells. Scientific Reports, 8 (1).
Offermann, A. , Schneider, F. , Hupe, M. C. , Hohensteiner, S. , Becker, F. , Carlsson, J. , Kirfel, J. , Svensson, M. & et al. (2018). TRIM24 as Independent Prognostic Marker in Prostate Cancer. Modern Pathology, 31 (Suppl. 2), 372-373.
Pernar, C. H. , Fall, K. , Rider, J. R. , Markt, S. C. , Adami, H. , Andersson, S. , Valdimarsdottir, U. , Andrén, O. & et al. (2017). A Walking Intervention Among Men With Prostate Cancer: A Pilot Study. Clinical Genitourinary Cancer, 15 (6), e1021-e1028.
Stopsack, K. H. , Gerke, T. A. , Andrén, O. , Andersson, S. , Giovannucci, E. L. , Mucci, L. A. & Rider, J. R. (2017). Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis, 38 (8), 806-811.
Downer, M. K. , Batista, J. L. , Mucci, L. A. , Stampfer, M. J. , Epstein, M. M. , Håkansson, N. , Wolk, A. , Johansson, J. & et al. (2017). Dairy intake in relation to prostate cancer survival. International Journal of Cancer, 140 (9), 2060-2069.
Lu, D. , Carlsson, J. , Penney, K. L. , Davidsson, S. , Andersson, S. , Mucci, L. A. , Valdimarsdóttir, U. , Andrén, O. & et al. (2017). Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease. Cancer Epidemiology, Biomarkers and Prevention, 26 (12), 1781-1787.
Rider, J. R. , Erlandsson, A. , Vyas, C. , Davidsson, S. , Carlsson, J. , Andersson, S. & Andren, O. (2017). iNOS expression and lethal prostate cancer in patients with localized disease. Cancer Research (22S).
Braegelmann, J. , Kluemper, N. , Offermann, A. , Von Maessenhausen, A. , Böhm, D. , Deng, M. , Queisser, A. , Sanders, C. & et al. (2017). Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer. Clinical Cancer Research, 23 (7), 1829-1840.
Zareba, P. , Flavin, R. , Isikbay, M. , Rider, J. R. , Gerke, T. A. , Finn, S. , Pettersson, A. , Giunchi, F. & et al. (2017). Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiology, Biomarkers and Prevention, 26 (5), 719-726.
Davidsson, S. , Carlsson, J. , Mölling, P. , Gashi, N. , Andrén, O. , Andersson, S. , Brzuszkiewicz, E. , Poehlein, A. & et al. (2017). Prevalence of Flp Pili-Encoding Plasmids in Cutibacterium acnes Isolates Obtained from Prostatic Tissue. Frontiers in Microbiology, 8.
Tyekucheva, S. , Bowden, M. , Bango, C. , Giunchi, F. , Huang, Y. , Zhou, C. , Bondi, A. , Lis, R. & et al. (2017). Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer. Nature Communications, 8 (1).
Stopsack, K. H. , Gerke, T. A. , Sinnott, J. A. , Penney, K. L. , Tyekucheva, S. , Sesso, H. D. , Andersson, S. , Andrén, O. & et al. (2016). Cholesterol Metabolism and Prostate Cancer Lethality. Cancer Research, 76 (16), 4785-4790.
Davidsson, S. , Mölling, P. , Rider, J. R. , Unemo, M. , Karlsson, M. G. , Carlsson, J. , Andersson, S. , Elgh, F. & et al. (2016). Erratum to: Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infectious Agents and Cancer, 11.
Ali, I. , Julin, B. , Glynn, A. , Högberg, J. , Berglund, M. , Johansson, J. , Andersson, S. , Andrén, O. & et al. (2016). Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies. Carcinogenesis, 37 (12), 1144-1151.
Davidsson, S. , Mölling, P. , Rider, J. R. , Unemo, M. , Karlsson, M. G. , Carlsson, J. , Andersson, S. , Elgh, F. & et al. (2016). Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infectious Agents and Cancer, 11.
Merz, C. , von Mässenhausen, A. , Queisser, A. , Vogel, W. , Andrén, O. , Kirfel, J. , Duensing, S. , Perner, S. & et al. (2016). IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2. American Journal of Pathology, 186 (4), 974-984.
Thorgeirsson, T. , Jordahl, K. M. , Flavin, R. , Epstein, M. M. , Fiorentino, M. , Andersson, S. , Andrén, O. , Rider, J. R. & et al. (2016). Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort. Carcinogenesis, 37 (3), 262-268.
Iglesias-Gato, D. , Wikström, P. , Tyanova, S. , Lavallee, C. , Thysell, E. , Carlsson, J. , Hägglöf, C. , Cox, J. & et al. (2016). The Proteome of Primary Prostate Cancer. European Urology, 69 (5), 942-952.
Persson, B. , Carringer, M. , Andren, O. , Andersson, S. , Carlsson, J. & Ljungqvist, O. (2015). Initial experiences with the enhanced recovery after surgery (ERAS (R)) protocol in open radical cystectomy. Scandinavian journal of urology, 49 (4), 302-307.
Martin, N. E. , Gerke, T. , Sinnott, J. A. , Stack, E. C. , Andrén, O. , Andersson, S. , Johansson, J. , Fiorentino, M. & et al. (2015). Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Molecular Cancer Research, 13 (10), 1431-1440.
Sinnott, J. A. , Rider, J. R. , Carlsson, J. , Gerke, T. , Tyekucheva, S. , Penney, K. L. , Sesso, H. D. , Loda, M. & et al. (2015). Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis, 36 (6), 632-638.
Svensson, M. A. , Perner, S. , Ohlson, A. , Day, J. R. , Groskopf, J. , Kirsten, R. , Sollie, T. , Helenius, G. & et al. (2014). A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. Applied immunohistochemistry & molecular morphology (Print), 22 (2), 136-141.
Salim, A. , Ma, X. , Fall, K. , Andrén, O. & Reilly, M. (2014). Analysis of incidence and prognosis from 'extreme' case-control designs. Statistics in Medicine, 33 (30), 5388-5398.
Svensson, M. A. , Nowak, M. , Vogel, W. , Carlsson, J. , Andrén, O. & Perner, S. (2014). Combination of Multiple Markers Predicts Prostate Cancer Outcome. Modern Pathology, 27, 262A-262A.
Offermann, A. , Shaikhibraim, Z. , Braun, M. , Menon, R. , Bohm, D. , Vogel, W. , Ruiz, C. , Zellweger, T. & et al. (2014). MED12 Is a Potential Target for Therapeutic Intervention in Castration Resistant Prostate Cancer. Modern Pathology, 27 (Suppl. 2), 466A-466A.
Shaikhibrahim, Z. , Offermann, A. , Braun, M. , Menon, R. , Syring, I. , Nowak, M. , Halbach, R. , Vogel, W. & et al. (2014). MED12 overexpression is a frequent event in castration-resistant prostate cancer. Endocrine-Related Cancer, 21 (4), 663-675.
Braun, M. , Shaikhibrahim, Z. , Menon, R. , Offermann, A. , Queisser, A. , Boehm, D. , Vogel, W. , Ruenauver, K. & et al. (2014). MED15, Encoding a Subunit of the Mediator Complex, Is Overexpressed at High Frequency in Castration-Resistant Prostate Cancer. Modern Pathology, 27, 219A-219A.
Shaikhibrahim, Z. , Menon, R. , Braun, M. , Offermann, A. , Queisser, A. , Boehm, D. , Vogel, W. , Rueenauver, K. & et al. (2014). MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer. International Journal of Cancer, 135 (1), 19-26.
Nowak, M. , Svensson, M. A. , Carlsson, J. , Vogel, W. , Kebschull, M. , Wernert, N. , Kristiansen, G. , Andren, O. & et al. (2014). Prognostic significance of phospho-histone H3 in prostate carcinoma. World journal of urology, 32 (3), 703-707.
Rueenauver, K. , Menon, R. , Svensson, M. A. , Carlsson, J. , Vogel, W. , Andrén, O. , Nowak, M. , Perner, S. & et al. (2014). Prognostic significance of YWHAZ expression in localized prostate cancer. Prostate Cancer and Prostatic Diseases, 17 (4), 310-314.
Bill-Axelson, A. , Holmberg, L. , Garmo, H. , Rider, J. R. , Taari, K. , Busch, C. , Nordling, S. , Häggman, M. & et al. (2014). Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer. New England Journal of Medicine, 370 (10), 932-942.
Blattner, M. , Lee, D. , O'Reilly, C. , Park, K. , MacDonald, T. Y. , Khani, F. , Turner, K. , Wild, P. J. & et al. (2014). SPOP mutations in prostate cancer across demographically diverse patient cohorts. Cancer Research, 74 (19).
Blattner, M. , Lee, D. J. , O'Reilly, C. , Park, K. , MacDonald, T. Y. , Khani, F. , Turner, K. R. , Chiu, Y. & et al. (2014). SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts. Neoplasia, 16 (1), 14-U34.
Davidsson, S. , Ohlson, A. , Andersson, S. , Fall, K. , Meisner, A. , Fiorentino, M. , Andrén, O. & Rider, J. R. (2013). CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer. Modern Pathology, 26 (3), 448-455.
Wilson, K. M. , Balter, K. , Moller, E. , Adami, H. , Andrén, O. , Andersson, S. , Gronberg, H. & Mucci, L. A. (2013). Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study. Cancer Causes and Control, 24 (8), 1575-1581.
Discacciati, A. , Orsini, N. , Andersson, S. , Andrén, O. , Johansson, J. , Mantzoros, C. S. & Wolk, A. (2013). Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study. Annals of Oncology, 24 (7), 1912-1918.
Carlsson, J. , Helenius, G. , Karlsson, M. G. , Andrén, O. , Klinga-Levan, K. & Olsson, B. (2013). Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate. BMC Cancer, 13.
Kirrander, P. , Andrén, O. & Windahl, T. (2013). Dynamic sentinel node biopsy in penile cancer: initial experiences at a Swedish referral centre. BJU International, 111 (3B), E48-E53.
Rider, J. R. , Sandin, F. , Andrén, O. , Wiklund, P. , Hugosson, J. & Stattin, P. (2013). Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study. European Urology, 63 (1), 88-96.
Möller, E. , Galeone, C. , Andersson, T. M. , Bellocco, R. , Adami, H. , Andrén, O. , Grönberg, H. , La Vecchia, C. & et al. (2013). Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case-control study. Journal of Nutritional Science, 2.
Popiolek, M. , Rider, J. R. , Andrén, O. , Andersson, S. , Holmberg, L. , Adami, H. & Johansson, J. (2013). Natural history of early, localized prostate cancer: A final report from three decades of follow-up. European Urology, 63 (3), 428-435.
Lyth, J. , Andersson, S. , Andrén, O. , Johansson, J. , Carlsson, P. & Shahsavar, N. (2012). A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer. Scandinavian Journal of Urology and Nephrology, 46 (1), 19-25.
Olsson, J. , Davidsson, S. , Unemo, M. , Molling, P. , Andersson, S. , Andrén, O. , Söderquist, B. , Sellin, M. & et al. (2012). Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 120 (10), 778-785.
Julin, B. , Wolk, A. , Johansson, J. , Andersson, S. , Andrén, O. & Åkesson, A. (2012). Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study. British Journal of Cancer, 21 (5), 895-900.
Epstein, M. M. , Kasperzyk, J. L. , Mucci, L. A. , Giovannucci, E. , Price, A. , Wolk, A. , Håkansson, N. , Fall, K. & et al. (2012). Dietary fatty acid intake and prostate cancer survival in Örebro county, Sweden. American Journal of Epidemiology, 176 (3), 240-252.
Davidsson, S. , Söderquist, B. , Elgh, F. , Olsson, J. , Andrén, O. , Unemo, M. & Mölling, P. (2012). Multilocus sequence typing and repetitive-sequence-based PCR (DiversiLab) for molecular epidemiological characterization of Propionibacterium acnes isolates of heterogeneous origin. Anaerobe, 18 (4), 392-399.
Epstein, M. M. , Andrén, O. , Kasperzyk, J. L. , Shui, I. M. , Penney, K. L. , Fall, K. , Rider, J. R. , Stampfer, M. J. & et al. (2012). Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue. Cancer Causes and Control, 23 (8), 1359-1366.
Lehmann, S. , Bykov, V. , Ali, D. , Andrén, O. , Cherif, H. , Tidefelt, U. , Uggla, B. , Yachnin, J. & et al. (2012). Targeting p53 in vivo: a first-in-man study with the p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. Journal of Clinical Oncology, 30 (29), 3633-3639.
Fiore, C. , Bailey, D. , Conlon, N. , Wu, X. , Martin, N. , Fiorentino, M. , Finn, S. , Fall, K. & et al. (2012). Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. Journal of Clinical Pathology, 65 (6), 496-502.
Carlsson, J. , Davidsson, S. , Helenius, G. , Karlsson, M. , Lubovac, Z. , Andrén, O. , Olsson, B. & Klinga-Levan, K. (2011). A miRNA expression signature that separates between normal and malignant prostate tissues. Cancer Cell International (11), 14.
Discacciati, A. , Orsini, N. , Andersson, S. , Andrén, O. , Johansson, J. & Wolk, A. (2011). Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study. British Journal of Cancer, 105 (7), 1061-1068.
Epstein, M. M. , Kasperzyk, J. L. , Andrén, O. , Giovannucci, E. L. , Wolk, A. , Håkansson, N. , Andersson, S. , Johansson, J. & et al. (2011). Dietary zinc and prostate cancer survival in a Swedish cohort. American Journal of Clinical Nutrition, 93 (3), 586-593.
Flaberg, E. , Markasz, L. , Petranyi, G. , Stuber, G. , Dicsö, F. , Alchihabi, N. , Oláh, E. , Csízy, I. & et al. (2011). High-throughput live cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. International Journal of Cancer, 128 (12), 2793-2802.
Kirrander, P. , Kolaric, A. , Helenius, G. , Windahl, T. , Andrén, O. , Stark, J. R. , Lillsunde-Larsson, G. , Elgh, F. & et al. (2011). Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma. BJU International, 108 (3), 355-359.
Davidsson, S. , Fiorentino, M. , Andrén, O. , Fang, F. , Mucci, L. A. , Varenhorst, E. , Fall, K. & Rider, J. R. (2011). Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiology, Biomarkers and Prevention, 20 (10), 2280-2287.
Andersson, S. , Andrén, O. , Lyth, J. , Stark, J. , Henriksson, M. , Adami, H. , Carlsson, P. & Johansson, J. (2011). Managing localized prostate cancer by radical prostatectomy or watchful waiting: cost analysis of a randomized trial (SPCG-4). Scandinavian Journal of Urology and Nephrology, 45 (3), 177-183.
Penney, K. L. , Sinnott, J. A. , Fall, K. , Pawitan, Y. , Hoshida, Y. , Kraft, P. , Stark, J. R. , Fiorentino, M. & et al. (2011). mRNA expression signature of Gleason grade predicts lethal prostate cancer. Journal of Clinical Oncology, 29 (17), 2391-2396.
Meyer, M. S. , Mucci, L. A. , Andersson, S. , Andrén, O. , Johansson, J. , Tretli, S. & Adami, H. (2010). Homogeneous prostate cancer mortality in the Nordic countries over four decades. European Urology, 58 (3), 427-32.
Sboner, A. , Demichelis, F. , Calza, S. , Pawitan, Y. , Setlur, S. R. , Hoshida, Y. , Perner, S. , Adami, H. & et al. (2010). Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Medical Genomics, 3.
Carlsson, J. , Helenius, G. , Karlsson, M. , Lubovac, Z. , Andrén, O. , Olsson, B. & Klinga-Levan, K. (2010). Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues. Cancer Genetics and Cytogenetics, 202 (2), 71-75.
Fall, K. , Fang, F. , Mucci, L. A. , Ye, W. , Andrén, O. , Johansson, J. , Andersson, S. , Sparén, P. & et al. (2009). Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Medicine, 6 (12), e1000197.
Fiorentino, M. , Mucci, L. , Fall, K. , Bailey, D. , Fiore, C. , Judson, G. , Andrén, O. , Andersson, S. & et al. (2009). Immunohistochemical Expression of BRCA1 in Prostate Cancer. Laboratory Investigation, 89, 169A-169A.
Fiorentino, M. , Mucci, L. , Fall, K. , Bailey, D. , Fiore, C. , Judson, G. , Andrén, O. , Andersson, S. & et al. (2009). Immunohistochemical Expression of BRCA1 in Prostate Cancer. Modern Pathology, 22, 169A-169A.
Andrén, O. , Garmo, H. , Mucci, L. , Andersson, S. , Johansson, J. & Fall, K. (2009). Incidence and mortality of incidental prostate cancer: a Swedish register-based study. British Journal of Cancer, 100 (1), 170-173.
Kasperzyk, J. L. , Fall, K. , Mucci, L. A. , Håkansson, N. , Wolk, A. , Johansson, J. , Andersson, S. & Andrén, O. (2009). One-carbon metabolism-related nutrients and prostate cancer survival. American Journal of Clinical Nutrition, 90 (3), 561-569.
Setlur, S. R. , Mertz, K. D. , Hoshida, Y. , Demichelis, F. , Lupien, M. , Perner, S. , Sboner, A. , Pawitan, Y. & et al. (2008). Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. Journal of the National Cancer Institute, 100 (11), 815-825.
Mucci, L. A. , Pawitan, Y. , Demichelis, F. , Fall, K. , Stark, J. R. , Adami, H. , Andersson, S. , Andrén, O. & et al. (2008). Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Cancer Epidemiology, Biomarkers and Prevention, 17 (1), 249-251.
Fall, K. , Strömberg, F. , Rosell, J. , Andrén, O. & Varenhorst, E. (2008). Reliability of death certificates in prostate cancer patients. Scandinavian Journal of Urology and Nephrology, 42 (4), 352-357.
Mucci, L. A. , Pawitan, Y. , Demichelis, F. , Fall, K. , Stark, J. R. , Adami, H. , Andersson, S. , Andrén, O. & et al. (2008). Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort. Cancer Epidemiology, Biomarkers and Prevention, 17 (7), 1682-1688.
Tomlins, S. A. , Rhodes, D. R. , Yu, J. , Varambally, S. , Mehra, R. , Perner, S. , Demichelis, F. , Helgeson, B. E. & et al. (2008). The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell, 13 (6), 519-28.
Adolfsson, J. , Garmo, H. , Varenhorst, E. , Ahlgren, G. , Ahlstrand, C. , Andren, O. , Bill-Axelson, A. , Bratt, O. & et al. (2007). Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005: Data from the national prostate cancer register in Sweden. Scandinavian Journal of Urology and Nephrology, 41 (6), 456-477.
Andrén, O. , Fall, K. , Andersson, S. , Rubin, M. A. , Bismar, T. A. , Karlsson, M. , Johansson, J. & Mucci, L. A. (2007). MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden. British Journal of Cancer, 97 (6), 730-734.
Fall, K. , Garmo, H. , Andrén, O. , Bill-Axelson, A. , Adolfsson, J. , Adami, H. , Johansson, J. & Holmberg, L. (2007). Prostate-specific antigen levels as a predictor of lethal prostate cancer. Journal of the National Cancer Institute, 99 (7), 526-532.
Demichelis, F. , Fall, K. , Perner, S. , Andrén, O. , Schmidt, F. , Setlur, S. , Hoshida, Y. , Mosquera, J. & et al. (2007). TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene, 26 (31), 4596-4599.
Andrén, O. , Fall, K. , Franzén, L. , Andersson, S. , Johansson, J. & Rubin, M. A. (2006). How well does the Gleason score predict prostate cancer death?: A 20-year followup of a population based cohort in Sweden. Journal of Urology, 175 (4), 1337-1340.
Rubin, M. A. , Bismar, T. A. , Andrén, O. , Mucci, L. , Kim, R. , Shen, R. L. , Ghosh, D. , Wei, J. T. & et al. (2005). Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiology, Biomarkers and Prevention, 14 (6), 1424-1432.
Johansson, J. , Andrén, O. , Andersson, S. , Dickman, P. W. , Holmberg, L. , Magnuson, A. & Adami, H. (2004). Natural history of early, localized prostate cancer. Journal of the American Medical Association (JAMA), 291 (22), 2713-2719.

Articles, reviews/surveys

Blomqvist, L. , Carlsson, S. , Gjertsson, P. , Heintz, E. , Hultcrantz, M. , Mejare, I. & Andrén, O. (2014). Limited evidence for the use of imaging to detect prostate cancer: a systematic review. European Journal of Radiology, 83 (9), 1601-1606.

Doctoral theses, comprehensive summaries

Andrén, O. (2008). Natural history and prognostic factors in localized prostate cancer. (Doctoral dissertation). (Comprehensive summary) Örebro: Örebro universitet.

Manuscripts

Svensson, M. A. , Perner, S. , Ohlson, A. , Day, J. R. , Kirsten, R. , Groskopf, J. , Sollie, T. , Helenius, G. & et al. A comparative study of ERG status assessment on DNA-, mRNA-, and proteinlevels using unique samples from a Swedish biopsy cohort.
Ugge, H. , Downer, M. K. , Carlsson, J. , Bowden, M. , Davidsson, S. , Mucci, L. A. , Fall, K. , Andersson, S. & et al. Circulating inflammation markers and prostate cancer.
Svensson, M. A. , Ohlson, A. , Sandblom, D. , Carlsson, J. , Andersson, S. , Andrén, O. & Rider, J. ERG rearrangement status and castration resistant prostate cancer : a prospective,population-based study.
Davidsson, S. , Mölling, P. , Unemo, M. , Rider, J. R. , Karlsson, M. G. , Andersson, S. , Elgh, F. , Andrén, O. & et al. Prevalence and typing of Propionibacterium acnes in prostate tissue obtained from men with prostate cancer and from health controls.